Venture-capital backed Prosonix Ltd has entered into a research agreement with Imperial College London to accelerate development of technology that is intended to improve the delivery of respiratory medicines. Financial terms weren’t disclosed. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
